A novel agent targeting APRIL: A new hope for elderly patients of IgA nephropathy
Sibeprenlimab is a humanized IgG2 monoclonal antibody that binds to and neutralizes the activity of APRIL. It should usher in a new era in the treatment of IgAN, especially in elderly patients.
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2025-02-01
|
| Schriftenreihe: | Aging Medicine |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1002/agm2.12370 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|